Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4041-4046, September 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barker, D.
Right arrow Articles by Abdel-Malek, Z. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, D.
Right arrow Articles by Abdel-Malek, Z. A.

Comparison of the Responses of Human Melanocytes with Different Melanin Contents to Ultraviolet B Irradiation1

Diane Barker, Kathleen Dixon, Estela E. Medrano2, Douglas Smalara, Sungbin Im, David Mitchell, George Babcock and Zalfa A. Abdel-Malek3

Departments of Dermatology [D. B. E. E. M., D. S., S. I., Z. A. A.] and Environmental Health [K. D.], University of Cincinnati, Cincinnati, Ohio 45267-0592; Department of Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Houston, TX [D. M.]; and Shriners Burns Institute, Cincinnati, Ohio [G. B.]

Melanin is thought to serve in photoprotection. To investigate this, we have compared the responses of cultured human melanocytes derived from different pigmentary phenotypes (skin types I–VI) to a single irradiation with different doses of UVB light, ranging between 11.7 and 70.1 mJ/cm2. After UVB irradiation, heavily pigmented melanocytes had the same percent survival but a greater capacity to resume proliferation than their lightly pigmented counterparts. A significant increase in melanin content was observed in heavily pigmented but not in lightly pigmented melanocytes. Irradiation with UVB light blocked melanocytes, regardless of their melanin content, in G1, and induced the expression of the tumor suppressor p53 protein within 4 h. This induction steadily increased up to 48 h in lightly pigmented melanocytes; however, in heavily pigmented melanocytes, p53 level peaked at 24 h after UVB treatment and declined thereafter. Additionally, DNA from lightly pigmented melanocytes contained significantly higher numbers of cyclobutane pyrimidine dimers than did DNA from heavily pigmented melanocytes after irradiation with increasing doses of UVB light. We speculate that the prolonged induction of p53 in lightly pigmented melanocytes arrests them in G1 for a long time period in order to repair extensive DNA damage. The above described differences might partially explain the increased susceptibility of individuals with lightly pigmented skin compared to individuals with dark skin to the photodamaging and photocarcinogenic effects of sun exposure.

1 Supported in part by a grant from the Ohio Cancer Research Associates; National Institute of Environmental Health Sciences Grants 1 R01 ES06882-01A1 (Z.A.M.) and 5P30 ES06096-02; Shiseido Co., Ltd. (Z.A.M.); and NIH National Institute on Aging Grant AG00594-02 (E.E.M.).

2 Present address: Baylor College of Medicine, Huffington Center on Aging, One Baylor Plaza, Houston, TX.

3 To whom requests for reprints should be addressed, at Department of Immunology, University of Cincinnati, P.O. Box 670592, Cincinnati, OH 45267-0592.

Received 3/15/95. Accepted 7/19/95.




This article has been cited by other articles:


Home page
FASEB J.Home page
Z. A. Abdel-Malek, A. L. Kadekaro, R. J. Kavanagh, A. Todorovic, L. N. Koikov, J. C. McNulty, P. J. Jackson, G. L. Millhauser, S. Schwemberger, G. Babcock, et al.
Melanoma prevention strategy based on using tetrapeptide {alpha}-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity
FASEB J, July 1, 2006; 20(9): 1561 - 1563.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Kadekaro, R. Kavanagh, H. Kanto, S. Terzieva, J. Hauser, N. Kobayashi, S. Schwemberger, J. Cornelius, G. Babcock, H. G. Shertzer, et al.
{alpha}-Melanocortin and Endothelin-1 Activate Antiapoptotic Pathways and Reduce DNA Damage in Human Melanocytes
Cancer Res., May 15, 2005; 65(10): 4292 - 4299.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bohm, I. Wolff, T. E. Scholzen, S. J. Robinson, E. Healy, T. A. Luger, T. Schwarz, and A. Schwarz
{alpha}-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA Damage
J. Biol. Chem., February 18, 2005; 280(7): 5795 - 5802.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. C. Scott, K. Wakamatsu, S. Ito, A. L. Kadekaro, N. Kobayashi, J. Groden, R. Kavanagh, T. Takakuwa, V. Virador, V. J. Hearing, et al.
Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation
J. Cell Sci., January 6, 2002; 115(11): 2349 - 2355.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Autier, R. Pedeux, and J.-F. Dore
RESPONSE: Re: Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial
J Natl Cancer Inst, December 1, 1999; 91(23): 2047 - 2047.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.